The Europe Natural Killer (NK) Cell Therapeutics Market was valued at USD 0.00 Billion in 2023 and is expected to reach USD 0.00 Billion by 2030, growing at a CAGR of 43.3% (2024-2030).
The Subcutaneous Nucleic Acid Therapeutics market was valued at USD 2.88 Billion in 2024 and is expected to reach USD 5.02 Billion by 2032, growing at a CAGR of 7.2% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.